Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

168.16
-0.6500-0.39%
Pre-market: 168.490.3300+0.20%08:18 EDT
Volume:11.12M
Turnover:1.86B
Market Cap:43.39B
PE:-11.83
High:168.51
Open:168.23
Low:165.19
Close:168.81
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:1.37
T/O Rate:4.31%
Dividend:2.45
Dividend Rate:1.45%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.26
PE(LYR):-11.83

Loading ...

Health Insurers Fall After UnitedHealthcare, Aetna Announce 2027 Plan Designs

Reuters
·
Oct 02

Health Care Roundup: Market Talk

Dow Jones
·
Oct 02

Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics

TIPRANKS
·
Oct 01

Analysts Offer Insights on Healthcare Companies: Zentek (OtherZTEKF) and Dr Reddy’s Laboratories (RDY)

TIPRANKS
·
Oct 01

National Healthcare Properties Making Progress to Increase SHOP Mix, RBC Capital Markets Says

MT Newswires Live
·
Oct 01

Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX) and Compugen (CGEN)

TIPRANKS
·
Oct 01

AbbVie Says Phase 3 Trials Show Rinvoq Vitiligo Repigmentation Gains Extend to Week 76

Reuters
·
Oct 01

Abbvie - Phase 3 Studies Show Continued Repigmentation with Rinvoq Through Week 76

THOMSON REUTERS
·
Oct 01

Abbvie - Rinvoq Plus NB-Uvb Shows Higher Repigmentation than Rinvoq Alone

THOMSON REUTERS
·
Oct 01

Definitive Healthcare joins Network Advertising Initiative

TIPRANKS
·
Oct 01

Omega Healthcare Announces New CEO and Board Transition

TIPRANKS
·
Oct 01

Health Care Select Sector SPDR: Pivot points

TIPRANKS
·
Oct 01

AbbVie to Host Third-Quarter 2026 Earnings Call Webcast

Reuters
·
Oct 01

Foghorn Therapeutics Slashes Jobs After Ending Cancer Drug Trials with Ely Lilly

Dow Jones
·
Oct 01

Jefferies Adjusts Price Target on Merck & Co to $177 From $175, Keeps Buy Rating

MT Newswires Live
·
Oct 01

InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development

Reuters
·
Oct 01

3 Australian AI Healthcare Stocks With Revenue Growth Up To 49%

Simply Wall St.
·
Oct 01

Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division

Reuters
·
Oct 01

Lilly Says Foundayo Cuts Predicted 10-Year Type 2 Diabetes Risk 57% in Attain-1 Post-Hoc Analysis

Reuters
·
Oct 01

Eli Lilly - Foundayo 17.2 Mg Associated with 57% Reduction in Diabetes Risk, 18% in Cardiovascular Risk Versus Placebo

Reuters
·
Oct 01